α-fibrinogenases

Current Drug Targets - Cardiovascular and Haematological Disorders

Volumn 4, Issue 4, 2004, Pages 417-435

  Swenson, S ^a   Toombs, C F ^b   Pena, L ^c   Johansson, J ^c   Markland, Jr ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b AMGEN INC   (United States)

^c Nuvelo Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMALYSIN; ALFIMEPRASE; ANISTREPLASE; ARGINYLGLYCYLASPARTIC ACID; ATROLYSIN C; ATROXASE; BRADYKININ ANTAGONIST; FIBRINOGEN RECEPTOR ANTAGONIST; FIBROLASE; LEBETASE; MACROGOL; METALLOPROTEINASE; PLASMIN; PLASMINOGEN ACTIVATOR DERIVATIVE; REPROLYSIN; SERINE; UNCLASSIFIED DRUG; UROKINASE; VENOMBIN A; VIPER VENOM;

AGKISTRODON; ARTERY THROMBOSIS; BINDING COMPETITION; BIOCHEMISTRY; BIRD; BLEEDING; BLOOD VESSEL OCCLUSION; BRAIN BLOOD VESSEL; BRAIN HEMORRHAGE; CHEMICAL MODIFICATION; CHEMICAL PROCEDURES; CHIMERA; CLINICAL FEATURE; CLINICAL TRIAL; DRUG BINDING; DRUG CLEARANCE; DRUG HALF LIFE; DRUG INDICATION; DRUG ISOLATION; DRUG MECHANISM; FIBRINOLYSIS; HEART BLOOD VESSEL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTRAVASCULAR CATHETER; MEDICAL LITERATURE; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICAL CHEMISTRY; REVIEW; SNAKE; STRUCTURE ACTIVITY RELATION; THROMBOCYTE; THROMBOCYTE AGGREGATION INHIBITION; THROMBOGENESIS; VASCULAR ACCESS; VEIN THROMBOSIS;

AGKISTRODON; ANIMALS; FIBRINOLYTIC AGENTS; HUMANS; METALLOENDOPEPTIDASES; PROTEIN CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP; VIPER VENOMS;

EID: 9444281936     PISSN: 15680061     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568006043335754     Document Type: Review

References (67)

1. Didisheim, P. and Lewis, J.H. Fibrinolytic and coagulant activities of certain snake venoms and proteases. Proc. Soc. Exptl. Biol. Med., 1956, 93, 10-13.
2. Kornalik, F. and Styblova, Z. Fibrinolytic proteases in snake venoms. Experientia, 1967, 23(12), 999-1000.
3. Bajwa, S.S., Kirakossian, H., Reddy, K.N.N. and Markland, F.S. Thrombin-like and fibrinolytic enzymes in the venoms from the Gaboon viper (Bits gabonica), eastern cottonmouth (Agkistrodon p. piscivorus) and southern copperhead (Agkistrodon c. contortrix) snakes. Toxicon. 1982, 20, 427-432.
4. Randolph, A., Chamberlain, S.H., Chu, H.L., Retzios, A.D., Markland, F.S. and Masiarz, F.R. Amino Acid sequence of fibrolase, a direct-acting fibrinolytic enzyme from Agkistrodon contortrix contortrix venom. Protein Sci., 1992, 1, 590-600.
5. Markland, F.S., Morris, S., Deschamps, J.R. and Ward, K.B. Resolution of isoforms of natural and recombinant fibrinolytic snake venom enzyme using high performance capillary electrophoresis. J. Liquid Chromatogr., 1993, 16, 2189-2201.
6. Retzios, A.D. and Markland, F.S. A direct-acting fibrinolytic enzyme from the venom of Agkistrodon contortrix contortrix: effects On various components of the human blood coagulation and fibrinolytic systems. Thromb. Res., 1988, 52, 541-552.
7. Markland, F.S., Reddy, K.N. and Guan, L. Purification and characterization of a direct-acting-fibrinolytic enzyme from southern copperhead venom. In Hemostasis and Animal Venoms, H. Pirkle and F.S. Markland, eds. (New York: Marcel Dekker), 1988, pp. 173-189.
8. Markland, F.S. Fibrolase, an active thrombolytic enzyme in arterial and venous thrombosis model systems. Adv. Exp. Med. Biol., 1996, 391, 427-438.
9. Markland, F.S., Friederichs G. S., Pewit S. A. and Lucchesi, B.R. Thrombolytic effects of recombinant fibrolase or APSAC in a canine model of carotid artery thrombosis. Circulation, 1994, 90 2448-2456.
10. Guan, A.L., Retzios, A.D., Henderson, G.N. and Markland, F.S. Purification and characterization of a fibrinolytic enzyme from the venom of the southern copperhead snake (Agkistrodon contortrix contortrix). Arch. Biochem. Biophys., 1991, 289, 197-207.
11. Retzios, A.D. and Markland, F.S., Jr. Purification, characterization, and fibrinogen cleavage sites of three fibrinolytic enzymes from the venom of Crotalus basiliscus basiliscus. Biochemistry 1992, 3(19), 4547-4557.
12. Guan, A.L. and Markland, F.S., Jr. Isoelectric focusing in immobilized pH gradients of a snake venom fibrinolytic enzyme. J. Biochem. Biophys. Meth., 1988, 16(2-3), 215-226.
13. Pretzer, D., Schulteis, B., Vander Velde, D.G., Smith, C.D., Mitchell, J.W. and Manning, M.C. Effect of zinc binding on the structure and stability of fibrolase, a fibrinolytic protein from snake venom. Pharm. Res., 1992, 9(7), 870-877.
14. Manning, M.C. Sequence analysis of fibrolase, a fibrinolytic metalloproteinase from Agkistrodon contortrix contortrix. Toxicon., 1995, 33(9), 1189-1200.
15. Loayza, S.L., Trikha M., Markland F. S., Riquelme P. and Kuo, J. Resolution of isoforms of natural and recombinant fibrolase, the fibrinolytic enzyme from Agkistrodon contortrix contortrix snake venom, and comparison of their EDTA sensitivities. J. Chromatog. B., 1994, 662, 227-243.
16. Bode, W., Gomis Ruth, F.X. and Stockler, W. Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins'. FEBS Lett. 1993, 331 (1-2), 134-140.
17. Bolger, M.B., Swenson, S. and Markland, F.S., Jr. Three-dimensional structure of fibrolase, the fibrinolytic enzyme from southern copperhead venom, modeled from the X-ray structure of adamalysin II and atrolysin C. AAPS Pharm. Sci., 2001, 3(2), E16.
18. Gomis Ruth, F.X., Kress, L.F., Kellermann, J., Mayr, I., Lee, X., Huber, R. and Bode, W. Refined 2.0 A X-ray crystal structure of the snake venom zinc-endopeptidase adamalysin II. Primary and tertiary structure determination, refinement, molecular structure and comparison with astacin, collagenase and thermolysin. J. Mol. Biol., 1994, 239(4), 513-544.
19. Zhang, D., Botos, I., Gomis-Ruth, F.X., Doll, R., Blood, C., Njoroge, F.G., Fox, J.W., Bode, W. and Meyer, E.F. Structural interaction of natural and synthetic inhibitors with the venom metalloproteinase, atrolysin C (form d). Proc. Natl. Acad. Sci. USA, 1994, 91 18), 8447-8451.
20. Burch, R.M., Farmer, S.G. and Steranka, L.R. Bradykinin receptor antagonists. Med Res. Rev., 1990, 10(2), 237-269.
21. Swenson, S., Bush, L.R. and Markland, F.S. Chimeric derivative of fibrolase, a fibrinolytic enzyme from southern copperhead venom, possesses inhibitory activity on platelet aggregation. Arch. Biochem. Biophys., 2000, 384(2), 227-237.
22. Siigur, E. and Siigur, J. Purification and characterization of lebetase, a fibrinolytic enzyme from Vipera lebetina (snake) venom. Biochim. Biophys. Acta, 1991, 1074(2), 223-229.
23. Siigur, J., Aaspollu, A., Tonismagi, K., Trummal, K., Samel, M., Vija, H., Subbi, J. and Siigur, E. Proteases from Vipera lebetina venom affecting coagulation and fibrinolysis. Haemostasis, 2001, 31(3-6), 123-132.
24. Trummal, K., Vija, H., Subbi, J. and Siigur, J. MALDI-TOF mass spectrometry analysis of substrate specificity of lebetase, a directacting fibrinolytic metalloproteinase from Vipera lebetina snake venom. Biochim. Biophys. Acta, 2000, 1476(2), 331-336.
25. Siigur, J., Samel, M., Tonismagi, K., Subbi, J., Siigur, E. and Tu, A.T. Biochemical characterization of lebetase, a direct-acting fibrinolytic enzyme from Vipera lebetina snake venom. Thromb. Res., 1998, 90(1), 39-49.
26. Siigur, E., Aaspollu, A., Tu, A.T. and Siigur, J. cDNA cloning and deduced amino acid sequence of fibrinolytic enzyme (lebetase) from Vipera lebetina snake venom. Biochem Biophys. Res. Commun., 1996, 224(1), 229-236.
27. Siigur, J., Tonismagi, K., Tu, A.T. and Siigur, E. Cross-reactivities of polyclonal antibodies against lebetase, fibrinolytic enzyme of Levantine viper (Vipera lebetina) venom. Toxicon., 1996, 34(5), 608-613.
28. Willis, T.W., Tu, A.T. and Miller, C.W. Thrombolysis with a snake venom protease in a rat model of venous thrombosis. Thromb. Res. 1989, 53(1), 19-29.
29. Tu, A.T., Baker, B., Wongvibulsin, S. and Willis, T. Biochemical characterization of atroxase and nucleotide sequence encoding the fibrinolytic enzyme. Toxicon., 1996, 34(11-12), 1295-1300.
30. Baker, B.J. and Tu, A.T. Atroxase - a fibrinolytic enzyme isolated from the venom of western diamondback rattlesnake. Isolation, characterization and cloning. Adv. Exp. Med. Biol., 1996, 391, 203-211.
31. Rael, E.D., Martinez, M. and Molina, O. Isolation of a fibrinolytic protease, M4, from venom of Crotalus molossus molossus (northern blacktail rattlesnake). Haemostasis, 1992, 22 1), 41-49.
32. Selistre-de-Araujo, H.S., de Souza, E.L., Beltramini, L.M., Ownby, C.L. and Souza. D.H. Expression, refolding, and activity of a recombinant nonhemorrhagic snake venom metalloprotease. Protein Expr. Purif., 2000, 19(1), 41-47.
33. Ramos, O.H., Carmona, A.K. and Selistre-de-Araujo, H.S. Expression, refolding, and in vitro activation of a recombinant snake venom pro-metalloprotease. Protein Expr. Purif., 2003, 28(1), 34-41.
34. Sanchez, E.F., Magalhaes, A., Mandelbaum, F.R. and Diniz, C.R. Purification and characterization of the hemorrhagic factor II from the venom of the bushmaster snake (Lachesis muta muta). Biochim. Biophys. Acta, 1991, 1074, 347-356.
35. Sanchez, E.F., Costa, M.I.E., Chavez-Olortegui, C., Assakura, M.T., Mandelbaum, F.R. and Diniz, C.R. Characterization of a hemorrhagic factor LHF-I, isolated from the bushmaster snake (Lachesis muta muta) venom. Toxicon., 1995, 33, 1653-1667.
36. Estevao-Costa, M.I., Diniz, C.R., Magalhaes, A., Markland, F.S. and Sanchez, E.F. Action of metalloproteinases mutalysin I and II on several components of the hemostatic and fibrinolytic systems. Thromb. Res., 2000, 99(4), 363-376.
37. Estevao-Costa, M.I., Martins, M.S., Sanchez, E.F., Diniz, C.R. and Chavez-Olortegui, C. Neutralization of the hemorrhagic activity of Bothrops and Lachesis snake venoms by a monoclonal antibody against mutalysin-II. Toxicon., 2000, 38(1), 139-144.
38. Souza, C.T., Moura, M.B., Magalhaes, A., Heneine, L.G., Olortegui, C.C., Diniz, C.R. and Sanchez, E.F. Inhibition of mutalysin II, a metalloproteinase from bushmaster snake venom by human alpha2-macroglobulin and rabbit immunoglobulin. Comp. Biochem. Physiol B Biochem. Mol. Biol., 2001, 130(2), 155-168.
39. Dyr, J.E., Blomback, B. and Kornalik, F. The fibrinogenolytic and procoagulant activity of southern copperhead venom enzymes. Thromb. Res., 1983, 30(3), 185-194.
40. Sanchez, E.F., Bush, L.R., Swenson, S. and Markland, F.S. Chimeric Fibrolase: Covalent Attachment of an RGD-Like Peptide to Create a Potentially More Effective Thrombolytic Agent. Thromb. Res., 1997, 87(3), 289-302.
41. Baker, P.L., Bullens, S., Bunting, S., Burdick, D.J., Chan, K.S., Deisher, T., Eigenbrot, C., Gadek, T.R., Gantzos, R., Lipari, M.T., Muir, C.D., Napier, M.N., Pitti, R.M., Padua, A., Quan, C., Stanley, M., Struble, M., Tom, J.Y.R. and Burnier, J.P. Cyclic RGD peptide analogues as antiplatelet antithrombotics. J. Med. Chem., 1992, 35 2040-2048.
42. Udvardy, M., Schwartzott, D., Jackson, K. and McKee, P.A. Hybrid peptide containing RGDF (Arg-Gly-Asp-Phe) coupled with the carboxy terminal part of alpha 2-antiplasmin capable of inhibiting platelet aggregation and promoting fibrinolysis. Blood Coagulation & Fibrinolysis, 1995, 6(1), 11-16.
43. Rote, W.E., Werns, S.W., Davis, J.H., Feigen, L.P., Kilgore, K.S. and Lucchesi, B.R. Platelet GPIIb/IIIa receptor inhibition by SC-49992 prevents thrombosis and rethrombosis in the canine carotid artery. Cardiovasc Res., 1993, 27(3), 500-507.
44. Topol, E.J. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. Lancet, 2001, 357(9272), 1905-1914.
45. Savonitto, S., Armstrong, P.W., Lincoff, A.M., Jia, G., Sila, C.A., Booth, J., Terrosu, P., Cavallini, C., White, H.D., Ardissino, D., Califf, R.M. and Topol, E.J. Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction. Dichotomous response as a function of age in the GUSTO V trial. Eur. Heart J., 2003, 24(20), 1807-1814.
46. Fujiwara, K., Matsumoto, N., Yagisawa, S., Tanimori, H., Kitagawa, T., Hirota, M., Hiratani, K., Fukushima, K., Tomonaga, A., Hara, K. and Yamamoto, K. Sandwich enzyme immunoassay of tumor-associated antigen sialosylated Lewisx using beta-D-galactosidase coupled to a monoclonal antibody of IgM isotype. J. Immunol. Meth., 1988, 112(1), 77-83.
47. Carter, J.M. Techniques for conjugation of synthetic peptides to carrier molecules. Meth. Mol. Biol., 1994, 36 155-191.
48. Bode, W., Grams, F., Reinemer, P., Gomis-Ruth, F.X., Baumann, U., McKay, D.B. and Stocker, W. The metzincin-superfamily of zinc-peptidases. Adv. Exp. Med. Biol., 1996, 389, 1-11.
49. Kumasaka, T., Yamamoto, M., Moriyama, H., Tanaka, N., Sato, M., Katsube, Y., Yamakawa, Y., Omori Satoh, T., Iwanaga, S. and Ueki, T. Crystal structure of H2-proteinase from the venom of Trimeresurus flavoviridis. J. Biochem. (Tokyo), 1996, 119(1), 49-57.
50. Ruggeri, Z.M. Mechanisms initiating platelet thrombus formation [published erratum appears in Thromb Haemost 1997 Oct;78(4):1304] [see comments]. Throm. Haemost., 1997, 78 1), 611-616.
51. Mustard, J.F., Packham, M.A. and Kinlough-Rathbone, R.L. Platelets, blood flow, and the vessel wall. Circulation, 1990, 81(1 Suppl), 24-27.
52. Toombs, C.F. Alfimeprase: pharmacology of a novel fibrinolytic metalloproteinase for thrombolysis. Haemostasis, 2001, 31(3-6), 141-147.
53. Laurel, C.B. and Jeppson, J.O. (1975). The Plasma Proteins. In The Plasma Protiens, Second Edition, Puttnam, F.W., ed. (New York: Academic Press). 1975, 1-47.
54. Werb, Z., Burleigh, M.C., Barrett, A.J. and Starkey, P.M. The Interaction of a2-Macroglobulin with Proteinases. Biochem. J., 1974, 139, 359-368.
55. Kolodziej, S.J., Klueppelberg, H.U., Nolasco, N., Ehses, W., Strickland, D.K. and Stoops, J.K. Three-dimensional structure of the human plasmin alpha2-macroglobulin complex. J. Struct. Biol., 1998, 123(2), 124-133.
56. Baramova, E.N., Shannon J. D., Bjarnason J. B., L., G.S. and Fox, J.W. Interaction of hemorrhagic metalloproteinases with human alpha 2-macroglobulin. Biochem., 1990, 29, 1069-1074.
57. Strickland, D.K., Larsson L. J., Neuenschwander D. E. and Bjork, I. Reaction of proteinases with a2-macroglobulin: rapid-kinetic evidence for a conformational rearrangement of the initial a2-macroglobulin-trypsin complex. Biochem., 1991, 30, 2797-2803.
58. Barrett, A.J. and Starkey, P.M. The interaction of alpha 2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism. Biochem. J., 1973, 133(4), 709-724.
59. Parnaud, G., Tache, S., Peiffer, G. and Corpet, D.E. Polyethyleneglycol suppresses colon cancer and causes dose-dependent regression of azoxymethane-induced aberrant crypt foci in rats. Cancer Res., 1999, 59(20), 5143-5147.
60. Harris, J.M., Martin, N.E. and Modi, M. Pegylation: a novel process for modifying pharmacokinetics. Clin. Pharmacokinet., 2001, 40(7), 539-551.
61. Clark, R., Olsen, K., Fhu, G., Marian, M., Mortensen, M., Teshima, G., Chang, S., Chu, H., Mukku, V., Canova-Davis, E., Somers, T., Cronin, M., Winkler, M. and Wells, J.A. Long acting growth hormones produced by conjugation with polyethyleneglycol. J. Biol. Chem., 1996, 271(36), 21969-21977.
62. Stocker, W., Grams, F., Baumann, U., Reinemer, P., Gomis Ruth, F.X, McKay, D.B. and Bode, W. The metzincins - topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci., 1995, 4(5), 823-840.
63. Bjork, I., Alriksson, E. and Ylinerjarvi, K. Kinetics of binding of chicken cystatin to papain. Biochem., 1989, 28 4), 1568-1573.
64. Jones, G., Ronk, M., Mori, F. and Zhang, Z. Disulfide structure of alfimeprase: a recombinant analog of fibrolase. Protein Sci., 2001, 10(6), 1264-1267.
65. Ahmed, N.K., Tennant, K.D., Markland, F.S. and Lacz, J.P. Biochemical characteristics of fibrolase, a fibrinolytic protease from snake venom. Haemostasis, 1990, 20(3), 147-154.
66. Ouriel, K., Veith, F.J. and Sasahara, A.A. Thrombolysis or peripheral arterial surgery: phase I results. TOPAS Investigators. J. Vasc. Surg., 1996, 23(1), 64-73.
67. Toombs, C.F. New directions in thrombolytic therapy. Curr. Opin. Pharmacol., 2001, 1(2), 164-168.